Skip to content

Evaluation of phototherapy on premature neonates

Comparison of the effect of prophylactic phototherapy with therapeutic phototherapy on serum bilirubin and neurodevelopment in 1500-2000-gr preterm neonates

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211015052778N1
Enrollment
200
Registered
2022-05-11
Start date
2022-06-22
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperbilirubinemia. Other disorders of bilirubin metabolism

Interventions

Intervention 1: Intervention group: infants will receive prophylactic phototherapy in the first 24 hours after birth. Phototherapy will be performed using a 5-DTA-lamp portable Phototherapy Equipment

Sponsors

Boushehr University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 4 Months

Inclusion criteria

Inclusion criteria: Premature infants weighing 1500-2000 gr

Exclusion criteria

Exclusion criteria: Dissatisfaction with participating in the study Asphyxia Cerebral hemorrhage Meningitis Neurological problems such as seizures without jaundice Structural brain problems Hypoxia Sepsis (positive blood culture) ABO incompatibility First-day jaundice

Design outcomes

Primary

MeasureTime frame
Total bilirubin. Timepoint: Measurement of total blood bilirubin at the beginning of the study (before the intervention) and then on days 1, 3, 5, 7 and 10 after birth. Method of measurement: In Shohadaye Khalije Fars Hospital, the bilirubin samples will be tested based on photometric principles and using Jendrssik Grof Assay kit from Biorex Fars Company through DIRUI CS-400 Auto-Chemistry Analyzer. In Salman Farsi Hospital, the bilirubin samples will be measured based on the same principles and kit used in the Shohadaye Khalije Fars Hospital using the DIRUI CS-400 Auto-Chemistry Analyzer.;Development. Timepoint: 2 and 4 month. Method of measurement: By ASQ questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoroush Ostadzade

Boushehr University of Medical Sciences

soorena767@gmail.com+98 77 3333 5250

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026